𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overall survival and PD-L1 expression in metastasized malignant melanoma

✍ Scribed by Jules Gadiot; Anna I. Hooijkaas; Andrew D. M. Kaiser; Harm van Tinteren; Hester van Boven; Christian Blank

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
623 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND:

Cancers are known to elude the immune system, for example, by MHC loss, FAS up‐regulation, or increased secretion of TGF‐beta. Recently, ligands of coinhibitory receptors like programmed cell death ligand–1 (PD‐L1, B7‐H1) have come to attention for their role in tumor immune escape. Various tumors have been tested for PD‐L1 expression, and conflicting results were obtained regarding its correlative impact on patient survival. This study aimed to determine the prognostic relevance of PD‐L1 expression for the survival of melanoma patients.

METHODS:

Paraffin‐embedded nevi, primary melanoma, and in‐transit, lymph node, and distant organ metastases from a set of 63 stages III‐IV melanoma patients referred to the Netherlands Cancer Institute between 2000 and 2004 for a sentinel‐node procedure or systemic therapy were studied. A large effort was invested in validating specific PD‐L1 staining. In addition to immunological factors such as T‐cell infiltration (CD8, CD4, and regulatory T cells), TGF‐beta and MHC‐I expression were assessed.

RESULTS:

Longitudinal analysis revealed no relevant PD‐L1 expression on primary melanoma compared with metastatic disease. No significant correlations with prognosis were found regarding immunological factors, whereas known prognostic markers such as Breslow thickness and sex could be confirmed. Analyses of the overall survival of our patient cohort did not reveal a negative association with PD‐L1 expression.

CONCLUSIONS:

Correlation of overall survival with PD‐L1 expression by melanoma cells remains controversial, and future clinical studies should focus on antibody validation and time of analysis in respect to disease progression. Cancer 2011. © 2010 American Cancer Society.

📜 SIMILAR VOLUMES

Immunohistochemical expression of nm23 i
Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome
✍ McDermott, Nuala C.; Milburn, Christina; Curran, Bernie; Kay, Elaine W.; Barry W 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

The objective of this study was to determine the utility of nm23 as an immunohistochemical indicator of prognosis in a large series (157 cases) of malignant melanoma and also in two subsets within this group: stage 1 tumours, whether in radial or vertical growth phase (140 cases); and stage 1 tumour

Activity, expression, and transcription
Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma
✍ Eleonore Fröhlich; Bettina Schlagenhauff; Matthias Möhrle; Ekkehard Weber; Chris 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Increased activity of the protease cathepsin B has been demonstrated in many tumor cells. A correlation of cathepsin B activity and metastatic potential of melanoma has been well established. ## METHODS. The cathepsins B, D, H, and L were evaluated in normal skin, nevi, and melanoma samples to ob

Expression of transporter associated wit
Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines
✍ Per Thor Straten; Alexei F. Kirkin; Tina Seremet; Jesper Zeuthen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 2 views

TAP1 and TAP2 molecules are involved in the transport of peptides prior to their association with class I molecules and are mandatory for efficient antigen presentation. To investigate whether loss of expression of TAP1 or TAP2 is a likely mechanism of immune escape in malignant melanoma, TAP1 and T

High expression levels of collagenase-1
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
✍ Johanna Nikkola; Pia Vihinen; Tatyana Vlaykova; Marjo Hahka-Kemppinen; Veli-Matt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 780 KB

## Abstract Matrix metalloproteinases (MMPs) are proteolytic enzymes capable of degrading extracellular matrix. Their role has been emphasized in tumor invasion, metastasis and tumor‐induced angiogenesis. We studied the expression of collagenase‐1 (MMP‐1), stromelysin‐1 (MMP‐3) and collagenase‐3 (M